(Circulation. 1995;91:66-71.)
© 1995 American Heart Association, Inc.
Articles |
Myocarditis in ß-Thalassemia Major
A Cause of Heart Failure
From the Cardiology Departments of Athens General Hospital and Hippokration Hospital, University of Athens Medical School, Greece.
Correspondence to Dimitrios Th. Kremastinos, MD, 2, Hatziyianni Mexi str, 115 28th Athens, Greece.
Background Although acute pericarditis is a common complication of ß-thalassemia major, the prevalence and consequences of myocarditis in this disease have not been investigated.
Methods and Results A prospective 5-year follow-up study was carried out in all patients with ß-thalassemia major in whom the diagnosis of acute infectious myocarditis could be established between 1977 and 1986. A similar number of age- and sex-matched control subjects with ß-thalassemia and normal left ventricular function and no evidence of myocarditis were also followed for 5 years. Of 1048 patients with ß-thalassemia major, 47 patients (age, 15±2.5 years) with precordial chest pain were diagnosed as having acute infectious myocarditis. Myocardial biopsy was diagnostic in 26 patients, borderline in 14 patients, and nondiagnostic in 7 patients. Acute heart failure with left ventricular dysfunction (left ventricular ejection fraction, 25±11%) developed in 11 patients (23.4%) with myocarditis, and 8 of them died within 1 month to 1 year after diagnosis. Thirteen patients with myocarditis (27.6%) developed chronic heart failure (left ventricular ejection fraction, 26±13%) within 3±1.3 years, and 10 of them died within 8±3 months. Left ventricular systolic and diastolic functions of the control subjects did not change significantly during the 5-year period (left ventricular ejection fraction, 63±11% versus 65±7%; P=NS). However, left ventricular restrictive abnormalities (early diastole/late diastole, >2.2; deceleration time, <110 milliseconds) combined with right ventricular dilatation (>30 mm internal diameter) and right-sided heart failure developed in 3 patients with extremely high mean serum ferritin levels. No significant difference was found in mean levels of serum ferritin and pretransfusion hemoglobin between patients with and those without myocarditis.
Conclusions In patients with ß-thalassemia, myocarditis appears to be involved in the pathogenesis of left ventricular systolic dysfunction, being the main cause of death. Iron overload appears to provoke left ventricular restrictive abnormalities combined with right ventricular enlargement and dysfunction.
Key Words: myocarditis • heart failure • ß-thalassemia
This article has been cited by other articles:
 |
|
 |
|
  A. M. Hamdy Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia Eur J Echocardiogr, March 1, 2007; 8(2): 102 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kramer, S. B. Murthi, R. M. Wise, I-T. Mak, and W. B. Weglicki Antioxidant and lysosomotropic properties of acute d-propranolol underlies its cardioprotection of postischemic hearts from moderate iron-overloaded rats. Experimental Biology and Medicine, April 1, 2006; 231(4): 473 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Farmakis, A. Polonifi, S. Deftereos, M. Tsironi, I. Papaioannou, and A. Aessopos Aortic Valve Replacement in a Patient With Thalassemia Intermedia Ann. Thorac. Surg., February 1, 2006; 81(2): 737 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y F Cheung, S Y Ha, and G C F Chan Ventriculo-vascular interactions in patients with {beta} thalassaemia major Heart, June 1, 2005; 91(6): 769 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Davis, C. O'Sullivan, P. H. Jarritt, and J. B. Porter Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major Blood, July 1, 2004; 104(1): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.F. Cheung, G. C.F. Chan, and S.Y. Ha Arterial Stiffness and Endothelial Function in Patients With {beta}-Thalassemia Major Circulation, November 12, 2002; 106(20): 2561 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Walker The heart in thalassaemia Eur. Heart J., January 2, 2002; 23(2): 102 - 105. [Full Text] [PDF]
|
|
|
|
|
|
G. Hahalis, A.S. Manolis, D. Apostolopoulos, D. Alexopoulos, A.G. Vagenakis, and N.C. Zoumbos Right ventricular cardiomyopathy in {beta}-thalassaemia major Eur. Heart J., January 2, 2002; 23(2): 147 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.J. Anderson, S. Holden, B. Davis, E. Prescott, C.C. Charrier, N.H. Bunce, D.N. Firmin, B. Wonke, J. Porter, J.M. Walker, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload Eur. Heart J., December 1, 2001; 22(23): 2171 - 2179. [Abstract] [PDF]
|
|
|
|
 |
|
 J. P. Kushner, J. P. Porter, and N. F. Olivieri Secondary Iron Overload Hematology, January 1, 2001; 2001(1): 47 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Kremastinos, P. Flevari, M. Spyropoulou, H. Vrettou, D. Tsiapras, and C. G. Stavropoulos-Giokas Association of Heart Failure in Homozygous {beta}-Thalassemia With the Major Histocompatibility Complex Circulation, November 16, 1999; 100(20): 2074 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Olivieri The {beta}-Thalassemias N. Engl. J. Med., July 8, 1999; 341(2): 99 - 109. [Full Text] [PDF]
|
|
|
|
|
|
E. Economou-Petersen, A. Aessopos, A. Kladi, P. Flevari, F. Karabatsos, C. Fragodimitri, P. Nicolaidis, H. Vrettou, D. Vassilopoulos, M. Karagiorga-Lagana, et al. Apolipoprotein E &b.epsi;4 Allele as a Genetic Risk Factor for Left Ventricular Failure in Homozygous beta -Thalassemia Blood, November 1, 1998; 92(9): 3455 - 3459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Olivieri and G. M. Brittenham Iron-Chelating Therapy and the Treatment of Thalassemia Blood, February 1, 1997; 89(3): 739 - 761. [Full Text] [PDF]
|
|